http://rxjournals.com Health and medical news to help you live a better life Fri, 12 Mar 2010 08:00:00 +0000 http://wordpress.org/?v=2.0.5 en http://rxjournals.com/survey-employers-plan-to-shift-more-health-costs-to-workers/ http://rxjournals.com/survey-employers-plan-to-shift-more-health-costs-to-workers/#comments Fri, 12 Mar 2010 08:00:00 +0000 Depression http://rxjournals.com/survey-employers-plan-to-shift-more-health-costs-to-workers/ News outlets report on new trends in health insurance for employers. The Washington Post: “Most big employers plan to shift a larger share of health-care costs to their workers next year, according to a survey to be released Thursday. …Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/survey-employers-plan-to-shift-more-health-costs-to-workers/feed/ http://rxjournals.com/cbio-secures-another-clinical-trial-milestone/ http://rxjournals.com/cbio-secures-another-clinical-trial-milestone/#comments Fri, 12 Mar 2010 07:00:00 +0000 Arthritis http://rxjournals.com/cbio-secures-another-clinical-trial-milestone/ Australian drug development company CBio Limited (ASX: CBZ) announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA)…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/cbio-secures-another-clinical-trial-milestone/feed/ http://rxjournals.com/cancer-patients-in-kent-gain-access-to-advanced-rapidarcr-radiotherapy-treatments-from-varian/ http://rxjournals.com/cancer-patients-in-kent-gain-access-to-advanced-rapidarcr-radiotherapy-treatments-from-varian/#comments Fri, 12 Mar 2010 07:00:00 +0000 Cancer http://rxjournals.com/cancer-patients-in-kent-gain-access-to-advanced-rapidarcr-radiotherapy-treatments-from-varian/ Cancer patients in Kent will gain access to advanced radiotherapy treatments with the decision by the Kent Oncology Centre to acquire two fully-equipped treatment machines from Varian Medical Systems (NYSE: VAR)…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/cancer-patients-in-kent-gain-access-to-advanced-rapidarcr-radiotherapy-treatments-from-varian/feed/ http://rxjournals.com/leading-varian-equipped-proton-therapy-center-treats-100th-patient/ http://rxjournals.com/leading-varian-equipped-proton-therapy-center-treats-100th-patient/#comments Fri, 12 Mar 2010 07:00:00 +0000 Cancer http://rxjournals.com/leading-varian-equipped-proton-therapy-center-treats-100th-patient/ Clinicians at the Rinecker Proton Therapy Center (RPTC) in Munich have treated their 100th patient using advanced proton therapy systems supplied by Varian Medical Systems (NYSE: VAR). The landmark treatment comes just three months after a second treatment gantry was commissioned at the center, which offers advanced pencil-beam proton scanning to cancer patients…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/leading-varian-equipped-proton-therapy-center-treats-100th-patient/feed/ http://rxjournals.com/can-multimedia-lead-to-more-informed-decisions-on-prostate-cancer-treatment/ http://rxjournals.com/can-multimedia-lead-to-more-informed-decisions-on-prostate-cancer-treatment/#comments Fri, 12 Mar 2010 06:00:00 +0000 Cancer http://rxjournals.com/can-multimedia-lead-to-more-informed-decisions-on-prostate-cancer-treatment/ Mount Sinai School of Medicine is leading a study of patients newly-diagnosed with prostate cancer to determine if providing them with multimedia materials can help them make more informed treatment decisions. Michael Diefenbach, Ph.D…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/can-multimedia-lead-to-more-informed-decisions-on-prostate-cancer-treatment/feed/ http://rxjournals.com/ark-therapeutics-ltd-withdraws-its-marketing-authorisation-application-for-cerepro-sitimagene-ceradenovec-europe/ http://rxjournals.com/ark-therapeutics-ltd-withdraws-its-marketing-authorisation-application-for-cerepro-sitimagene-ceradenovec-europe/#comments Fri, 12 Mar 2010 06:00:00 +0000 Cancer http://rxjournals.com/ark-therapeutics-ltd-withdraws-its-marketing-authorisation-application-for-cerepro-sitimagene-ceradenovec-europe/ The European Medicines Agency has been formally notified by Ark Therapeutics Ltd of its decision to withdraw its application for a centralised marketing authorisation for the advanced therapy medicinal product Cerepro (sitimagene ceradenovec). Cerepro received an orphan designation on 6 February 2002 and was intended for the treatment of patients with high-grade operable glioma…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/ark-therapeutics-ltd-withdraws-its-marketing-authorisation-application-for-cerepro-sitimagene-ceradenovec-europe/feed/ http://rxjournals.com/allons-phase-1-trial-broadens-davunetides-intranasal-safety-and-dose-range/ http://rxjournals.com/allons-phase-1-trial-broadens-davunetides-intranasal-safety-and-dose-range/#comments Fri, 12 Mar 2010 06:00:00 +0000 Alzheimers Disease http://rxjournals.com/allons-phase-1-trial-broadens-davunetides-intranasal-safety-and-dose-range/ Allon Therapeutics Inc. (TSX:NPC) announced today that a Phase 1 clinical trial of its lead neuroprotective drug, davunetide , which began patient enrolment January 28, 2010, has been completed. The results demonstrated that the intranasal dose range can be broadened and provided additional information on the pharmacokinetic profile of davunetide…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/allons-phase-1-trial-broadens-davunetides-intranasal-safety-and-dose-range/feed/ http://rxjournals.com/knee-replacement-in-elderly-patients-shown-to-improve-balance/ http://rxjournals.com/knee-replacement-in-elderly-patients-shown-to-improve-balance/#comments Fri, 12 Mar 2010 06:00:00 +0000 Arthritis http://rxjournals.com/knee-replacement-in-elderly-patients-shown-to-improve-balance/ Total knee replacement (TKR) successfully relieves pain and improves function in patients with advanced knee arthritis, according to a study presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The surgery also significantly improves dynamic balance among elderly patients…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/knee-replacement-in-elderly-patients-shown-to-improve-balance/feed/ http://rxjournals.com/thyroid-hormone-analogue-for-treating-high-cholesterol/ http://rxjournals.com/thyroid-hormone-analogue-for-treating-high-cholesterol/#comments Fri, 12 Mar 2010 06:00:00 +0000 Cholesterol http://rxjournals.com/thyroid-hormone-analogue-for-treating-high-cholesterol/ An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/thyroid-hormone-analogue-for-treating-high-cholesterol/feed/ http://rxjournals.com/mayo-clinic-receives-unique-philanthropic-gift-for-cancer-research/ http://rxjournals.com/mayo-clinic-receives-unique-philanthropic-gift-for-cancer-research/#comments Fri, 12 Mar 2010 05:00:00 +0000 Cancer http://rxjournals.com/mayo-clinic-receives-unique-philanthropic-gift-for-cancer-research/ Mayo Clinic is forming a new permanent professorship to augment cancer research that will focus on finding new treatments and preventive measures to reduce the incidence of cancer. This professorship is made possible by a $2 million gift from The Vasek and Anna Maria Polak Charitable Foundation, and the recipient, Keith Stewart, M.B., Ch.B., has been approved by the Mayo Clinic Board of Trustees…Original post by Allergy News From Medical News Today

]]> http://rxjournals.com/mayo-clinic-receives-unique-philanthropic-gift-for-cancer-research/feed/